137 related articles for article (PubMed ID: 11041101)
1. Anti-CD2 monoclonal antibodies prevent the induction of experimental autoimmune myocarditis.
Inomata T; Watanabe T; Haga M; Hirahara H; Abo T; Okura Y; Hanawa H; Kodama M; Izumi T
Jpn Heart J; 2000 Jul; 41(4):507-17. PubMed ID: 11041101
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
3. Immune tolerance to cardiac myosin induced by anti-CD4 monoclonal antibody in autoimmune myocarditis rats.
Wang QQ; Wang YL; Yuan HT; Liu FQ; Jin YP; Han B
J Clin Immunol; 2006 May; 26(3):213-21. PubMed ID: 16783461
[TBL] [Abstract][Full Text] [Related]
4. CTLA4-Ig abrogates the anti-globulin response and prolongs cardiac allograft survival after anti-CD2 treatment.
Stell D; Marshall H; Bradley JA; Bolton EM
Transpl Immunol; 2003; 12(1):1-7. PubMed ID: 14551027
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2.
Hirahara H; Tsuchida M; Watanabe T; Haga M; Matsumoto Y; Abo T; Eguchi S
Transplantation; 1995 Jan; 59(1):85-90. PubMed ID: 7839434
[TBL] [Abstract][Full Text] [Related]
6. Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells.
Li Y; Heuser JS; Kosanke SD; Hemric M; Cunningham MW
Am J Pathol; 2005 Jul; 167(1):5-15. PubMed ID: 15972947
[TBL] [Abstract][Full Text] [Related]
7. Anti-alpha beta T cell receptor antibody prevents the progression of experimental autoimmune myocarditis.
Hanawa H; Kodama M; Inomata T; Izumi T; Shibata A; Tuchida M; Matsumoto Y; Abo T
Clin Exp Immunol; 1994 Jun; 96(3):470-5. PubMed ID: 8004817
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway.
Afanasyeva M; Wang Y; Kaya Z; Stafford EA; Dohmen KM; Sadighi Akha AA; Rose NR
Circulation; 2001 Dec; 104(25):3145-51. PubMed ID: 11748115
[TBL] [Abstract][Full Text] [Related]
9. Initiation and perpetuation of rat adjuvant arthritis is inhibited by the anti-CD2 monoclonal antibody (mAb) OX34.
Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Rosenthal H; Westermann J
Ann Rheum Dis; 1997 Dec; 56(12):716-22. PubMed ID: 9496150
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD2 monoclonal antibodies prevent spontaneous and adoptive transfer of diabetes in the BB/Wor rat.
Barlow AK; Like AA
Am J Pathol; 1992 Nov; 141(5):1043-51. PubMed ID: 1359788
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD2 (OX34) MoAb treatment of adjuvant arthritic rats: attenuation of established arthritis, selective depletion of CD4+ T cells, and CD2 down-modulation.
Hoffmann JC; Herklotz C; Zeidler H; Bayer B; Westermann J
Clin Exp Immunol; 1997 Oct; 110(1):63-71. PubMed ID: 9353150
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats.
Liu W; Li WM; Gao C; Sun NL
J Autoimmun; 2005 Dec; 25(4):258-63. PubMed ID: 16242301
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway.
Haga T; Suzuki J; Kosuge H; Ogawa M; Saiki H; Haraguchi G; Maejima Y; Isobe M; Uede T
J Mol Cell Cardiol; 2009 May; 46(5):719-27. PubMed ID: 19233196
[TBL] [Abstract][Full Text] [Related]
14. T cell directed immunotherapy of inflammatory demyelination in the peripheral nervous system. Potent suppression of the effector phase of experimental autoimmune neuritis by anti-CD2 antibodies.
Jung S; Toyka K; Hartung HP
Brain; 1996 Aug; 119 ( Pt 4)():1079-90. PubMed ID: 8813272
[TBL] [Abstract][Full Text] [Related]
15. Beta2-Adrenergic agonists suppress rat autoimmune myocarditis: potential role of beta2-adrenergic stimulants as new therapeutic agents for myocarditis.
Nishii M; Inomata T; Niwano H; Takehana H; Takeuchi I; Nakano H; Shinagawa H; Naruke T; Koitabashi T; Nakahata J; Izumi T
Circulation; 2006 Aug; 114(9):936-44. PubMed ID: 16908771
[TBL] [Abstract][Full Text] [Related]
16. Effects of the anti-CD2 mAb OX34 on in vivo proliferation.
Hoffmann JC; Herklotz C; Zeitz M; Bayer B; Zeidler H; Westermann J
Ann N Y Acad Sci; 1998 Nov; 859():216-8. PubMed ID: 9928391
[TBL] [Abstract][Full Text] [Related]
17. T cells with similar T-cell receptor beta-chain complementarity-determining region 3 motifs infiltrate inflammatory lesions of synthetic peptides inducing rat autoimmune myocarditis.
Hanawa H; Inomata T; Okura Y; Hirono S; Ogawa Y; Izumi T; Kodama M; Aizawa Y
Circ Res; 1998 Jul; 83(2):133-40. PubMed ID: 9686752
[TBL] [Abstract][Full Text] [Related]
18. Treatment and prevention of experimental autoimmune myocarditis with CD28 superagonists.
Wang S; Liu J; Wang M; Zhang J; Wang Z
Cardiology; 2010; 115(2):107-13. PubMed ID: 19907173
[TBL] [Abstract][Full Text] [Related]
19. Polarity of helper T cell subsets represents disease nature and clinical course of experimental autoimmune myocarditis in rats.
Fuse K; Kodama M; Ito M; Okura Y; Kato K; Hanawa H; Aoki S; Aizawa Y
Clin Exp Immunol; 2003 Dec; 134(3):403-8. PubMed ID: 14632744
[TBL] [Abstract][Full Text] [Related]
20. Cardiosphere-Derived Cells Attenuate Inflammation, Preserve Systolic Function, and Prevent Adverse Remodeling in Rat Hearts With Experimental Autoimmune Myocarditis.
Nana-Leventaki E; Nana M; Poulianitis N; Sampaziotis D; Perrea D; Sanoudou D; Rontogianni D; Malliaras K
J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):70-77. PubMed ID: 30060693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
